β-amyloid burden in healthy aging: Regional distribution and cognitive consequences

K. M. Rodrigue, K. M. Kennedy, M. D. Devous, J. R. Rieck, A. C. Hebrank, R. Diaz-Arrastia, D. Mathews, D. C. Park

Research output: Contribution to journalArticle

208 Citations (Scopus)

Abstract

Objective: Several lines of evidence suggest that pathologic changes underlying Alzheimer disease (AD) begin years prior to the clinical expression of the disease, underscoring the need for studies of cognitively healthy adults to capture these early changes. The overall goal of the current study was to map the cortical distribution of β-amyloid (Aβ) in a healthy adult lifespan sample (aged 30-89), and to assess the relationship between elevated amyloid and cognitive performance across multiple domains. Methods: A total of 137 well-screened and cognitively normal adults underwent Aβ PET imaging with radiotracer 18F-florbetapir. Aβ load was estimated from 8 cortical regions. Participants were genotyped for APOE and tested for processing speed, working memory, fluid reasoning, episodic memory, and verbal ability. Results: Aβ deposition is distributed differentially across the cortex and progresses at varying rates with age across cortical brain regions. A subset of cognitively normal adults aged 60 and over show markedly elevated deposition, and also had a higher rate of APOE ε4 (38%) than nonelevated adults (19%). Aβ burden was linked to poorer cognitive performance on measures of processing speed, working memory, and reasoning. Conclusions: Even in a highly selected lifespan sample of adults, Aβ deposition is apparent in some adults and is influenced by APOE status. Greater amyloid burden was related to deleterious effects on cognition, suggesting that subtle cognitive changes accrue as amyloid progresses.

Original languageEnglish (US)
Pages (from-to)387-395
Number of pages9
JournalNeurology
Volume78
Issue number6
DOIs
StatePublished - Feb 7 2012

Fingerprint

Amyloid
Short-Term Memory
Aptitude
Episodic Memory
Cognition
Alzheimer Disease
Burden
Brain
Deposition

ASJC Scopus subject areas

  • Clinical Neurology
  • Arts and Humanities (miscellaneous)

Cite this

Rodrigue, K. M., Kennedy, K. M., Devous, M. D., Rieck, J. R., Hebrank, A. C., Diaz-Arrastia, R., ... Park, D. C. (2012). β-amyloid burden in healthy aging: Regional distribution and cognitive consequences. Neurology, 78(6), 387-395. https://doi.org/10.1212/WNL.0b013e318245d295

β-amyloid burden in healthy aging : Regional distribution and cognitive consequences. / Rodrigue, K. M.; Kennedy, K. M.; Devous, M. D.; Rieck, J. R.; Hebrank, A. C.; Diaz-Arrastia, R.; Mathews, D.; Park, D. C.

In: Neurology, Vol. 78, No. 6, 07.02.2012, p. 387-395.

Research output: Contribution to journalArticle

Rodrigue, KM, Kennedy, KM, Devous, MD, Rieck, JR, Hebrank, AC, Diaz-Arrastia, R, Mathews, D & Park, DC 2012, 'β-amyloid burden in healthy aging: Regional distribution and cognitive consequences', Neurology, vol. 78, no. 6, pp. 387-395. https://doi.org/10.1212/WNL.0b013e318245d295
Rodrigue KM, Kennedy KM, Devous MD, Rieck JR, Hebrank AC, Diaz-Arrastia R et al. β-amyloid burden in healthy aging: Regional distribution and cognitive consequences. Neurology. 2012 Feb 7;78(6):387-395. https://doi.org/10.1212/WNL.0b013e318245d295
Rodrigue, K. M. ; Kennedy, K. M. ; Devous, M. D. ; Rieck, J. R. ; Hebrank, A. C. ; Diaz-Arrastia, R. ; Mathews, D. ; Park, D. C. / β-amyloid burden in healthy aging : Regional distribution and cognitive consequences. In: Neurology. 2012 ; Vol. 78, No. 6. pp. 387-395.
@article{47efb7e762da401cab93ce576df68363,
title = "β-amyloid burden in healthy aging: Regional distribution and cognitive consequences",
abstract = "Objective: Several lines of evidence suggest that pathologic changes underlying Alzheimer disease (AD) begin years prior to the clinical expression of the disease, underscoring the need for studies of cognitively healthy adults to capture these early changes. The overall goal of the current study was to map the cortical distribution of β-amyloid (Aβ) in a healthy adult lifespan sample (aged 30-89), and to assess the relationship between elevated amyloid and cognitive performance across multiple domains. Methods: A total of 137 well-screened and cognitively normal adults underwent Aβ PET imaging with radiotracer 18F-florbetapir. Aβ load was estimated from 8 cortical regions. Participants were genotyped for APOE and tested for processing speed, working memory, fluid reasoning, episodic memory, and verbal ability. Results: Aβ deposition is distributed differentially across the cortex and progresses at varying rates with age across cortical brain regions. A subset of cognitively normal adults aged 60 and over show markedly elevated deposition, and also had a higher rate of APOE ε4 (38{\%}) than nonelevated adults (19{\%}). Aβ burden was linked to poorer cognitive performance on measures of processing speed, working memory, and reasoning. Conclusions: Even in a highly selected lifespan sample of adults, Aβ deposition is apparent in some adults and is influenced by APOE status. Greater amyloid burden was related to deleterious effects on cognition, suggesting that subtle cognitive changes accrue as amyloid progresses.",
author = "Rodrigue, {K. M.} and Kennedy, {K. M.} and Devous, {M. D.} and Rieck, {J. R.} and Hebrank, {A. C.} and R. Diaz-Arrastia and D. Mathews and Park, {D. C.}",
year = "2012",
month = "2",
day = "7",
doi = "10.1212/WNL.0b013e318245d295",
language = "English (US)",
volume = "78",
pages = "387--395",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - β-amyloid burden in healthy aging

T2 - Regional distribution and cognitive consequences

AU - Rodrigue, K. M.

AU - Kennedy, K. M.

AU - Devous, M. D.

AU - Rieck, J. R.

AU - Hebrank, A. C.

AU - Diaz-Arrastia, R.

AU - Mathews, D.

AU - Park, D. C.

PY - 2012/2/7

Y1 - 2012/2/7

N2 - Objective: Several lines of evidence suggest that pathologic changes underlying Alzheimer disease (AD) begin years prior to the clinical expression of the disease, underscoring the need for studies of cognitively healthy adults to capture these early changes. The overall goal of the current study was to map the cortical distribution of β-amyloid (Aβ) in a healthy adult lifespan sample (aged 30-89), and to assess the relationship between elevated amyloid and cognitive performance across multiple domains. Methods: A total of 137 well-screened and cognitively normal adults underwent Aβ PET imaging with radiotracer 18F-florbetapir. Aβ load was estimated from 8 cortical regions. Participants were genotyped for APOE and tested for processing speed, working memory, fluid reasoning, episodic memory, and verbal ability. Results: Aβ deposition is distributed differentially across the cortex and progresses at varying rates with age across cortical brain regions. A subset of cognitively normal adults aged 60 and over show markedly elevated deposition, and also had a higher rate of APOE ε4 (38%) than nonelevated adults (19%). Aβ burden was linked to poorer cognitive performance on measures of processing speed, working memory, and reasoning. Conclusions: Even in a highly selected lifespan sample of adults, Aβ deposition is apparent in some adults and is influenced by APOE status. Greater amyloid burden was related to deleterious effects on cognition, suggesting that subtle cognitive changes accrue as amyloid progresses.

AB - Objective: Several lines of evidence suggest that pathologic changes underlying Alzheimer disease (AD) begin years prior to the clinical expression of the disease, underscoring the need for studies of cognitively healthy adults to capture these early changes. The overall goal of the current study was to map the cortical distribution of β-amyloid (Aβ) in a healthy adult lifespan sample (aged 30-89), and to assess the relationship between elevated amyloid and cognitive performance across multiple domains. Methods: A total of 137 well-screened and cognitively normal adults underwent Aβ PET imaging with radiotracer 18F-florbetapir. Aβ load was estimated from 8 cortical regions. Participants were genotyped for APOE and tested for processing speed, working memory, fluid reasoning, episodic memory, and verbal ability. Results: Aβ deposition is distributed differentially across the cortex and progresses at varying rates with age across cortical brain regions. A subset of cognitively normal adults aged 60 and over show markedly elevated deposition, and also had a higher rate of APOE ε4 (38%) than nonelevated adults (19%). Aβ burden was linked to poorer cognitive performance on measures of processing speed, working memory, and reasoning. Conclusions: Even in a highly selected lifespan sample of adults, Aβ deposition is apparent in some adults and is influenced by APOE status. Greater amyloid burden was related to deleterious effects on cognition, suggesting that subtle cognitive changes accrue as amyloid progresses.

UR - http://www.scopus.com/inward/record.url?scp=84858121162&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858121162&partnerID=8YFLogxK

U2 - 10.1212/WNL.0b013e318245d295

DO - 10.1212/WNL.0b013e318245d295

M3 - Article

C2 - 22302550

AN - SCOPUS:84858121162

VL - 78

SP - 387

EP - 395

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 6

ER -